Crinetics Pharmaceuticals Lands $40,000,000 Series A Financing Round

  • Feed Type
  • Date
    11/3/2015
  • Company Name
    Crinetics Pharmaceuticals
  • Mailing Address
    6197 Cornerstone Court San Diego, CA 92121 USA
  • Company Description
    Crinetics Pharmaceuticals discovers and develops important new drugs for endocrinologists and their patients. Our internal discovery programs target peptide hormone receptors for the treatment of specialty endocrine disorders in the areas of neuroendocrinology, reproductive medicine, and women’s health.
  • Website
    http://www.crinetics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Crinetics plans to use the proceeds to advance development of its small molecule somatostatin agonist program to clinical proof-of-concept for the treatment of acromegaly, as well as to move additional programs into development.
  • M&A Terms
  • Venture Investor
    5AM Ventures
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Vivo Capital

Trending on Xconomy